Ingevity (NGVT) EBITDA (2015 - 2026)

Ingevity (NGVT) has reported EBITDA for 12 consecutive years, with $92.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 31.71% year-over-year to $92.2 million in Q2 2026; TTM through Jun 2026 was $278.6 million, a 6.91% increase from a year earlier, with the FY2025 full-year figure at $249.1 million, down 5.79% from the prior year.
• EBITDA was $92.2 million for Q2 2026 at Ingevity, up from $68.5 million in the prior quarter.
• Over five years, EBITDA peaked at $111.2 million in Q3 2022 and troughed at -$17.1 million in Q1 2024.
• A 5-year average of $62.0 million and a median of $68.0 million in 2023 frame the typical range for EBITDA.
• The widest YoY moves for EBITDA: up 619.05% in 2024, down 125.37% in 2024.
• Over 5 years, EBITDA stood at $39.1 million in 2022, then tumbled by 83.89% to $6.3 million in 2023, then soared by 619.05% to $45.3 million in 2024, then retreated by 20.31% to $36.1 million in 2025, then jumped by 155.4% to $92.2 million in 2026.
• The last three EBITDA figures came in at $92.2 million (Q2 2026), $68.5 million (Q1 2026), and $36.1 million (Q4 2025), per Business Quant data.